Dr. Jie Liu 刘杰
Chief Physician
Department of Head and Neck Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of head and neck tumors, including thyroid cancer, oropharyngeal and parapharyngeal tumors, oral cavity, nasal sinus, larynx, hypopharynx, and cervical esophageal tumors. Expertise in robotic and endoscopic thyroid surgery.
Dr. Liu holds a PhD in Oncology from Peking Union Medical College (2010) and graduated from Peking University Health Science Center (2004). A Chief Physician and doctoral supervisor, Dr. Liu specializes in surgical treatment and reconstruction of head and neck tumors, with a focus on primary and recurrent thyroid cancer and scarless thyroid surgery. Dr. Liu visited MD Anderson Cancer Center in the US in 2011.
Professional roles
- Member, Head and Neck Oncology Professional Committee, China Anti-Cancer Association
- Vice Chair, Youth Committee, Head and Neck Oncology Professional Committee, China Anti-Cancer Association
- Member, Thyroid Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Youth Committee, Thyroid Cancer Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Liu Jie). Papers usually list the name as Jie Liu or Liu J.
Selected publications
89 papers on PubMed matched by name and affiliation; 30 as first or senior author since 2016. Most recent first- or senior-author papers:
- Gland Surg, 2026 (senior author): The influence of clinically suspected metastatic lymph node distribution on occult metastasis and recurrence in papillary thyroid carcinoma. PubMed 41969936
- Oral Oncol, 2026 (senior author): Predicting occult lymph node metastasis in level II using preoperative factors. PubMed 41500182
- Int J Surg, 2026 (senior author): On-demand l -thyroxine replacement therapy in post-lobectomy papillary thyroid cancer: a prospective nonrandomized controlled study. PubMed 41208784
- J Clin Endocrinol Metab, 2024 (senior author): Synergy of Nodal Factors in Predicting Recurrence After Treatment of N1b Papillary Thyroid Carcinoma. PubMed 38748619
- Endocrine, 2024 (senior author): Extent of surgery for unilateral papillary thyroid cancer with nonsuspicious contralateral nodules by ultrasound. PubMed 38703328
- Heliyon, 2024 (first author): Exploring prognostic microbiota markers in patients with endometrial carcinoma: Intratumoral insights. PubMed 38515713
- BMC Cancer, 2023 (senior author): Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer. PubMed 37723469
- JAMA Surg, 2023 (senior author): Determining the Power Required for Comparing Lobectomy vs Total Thyroidectomy for Papillary Thyroid Carcinoma-Reply. PubMed 37195671
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion